Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands
© Westra et al.; licensee BioMed Central Ltd. 2013
Received: 22 May 2012
Accepted: 25 January 2013
Published: 7 February 2013
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|22 May 2012||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|Resubmission - Version 3|
|Submitted||Manuscript version 3|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|22 Jul 2012||Reviewed||Reviewer Report - Philippe Beutels|
|9 Aug 2012||Reviewed||Reviewer Report - Walter G W Ricciardi|
|14 Aug 2012||Reviewed||Reviewer Report - Eduardo Lazcano-Ponce|
|19 Oct 2012||Author responded||Author comments - Tjalke Westra|
|Resubmission - Version 5|
|19 Oct 2012||Submitted||Manuscript version 5|
|18 Nov 2012||Reviewed||Reviewer Report - Walter G W Ricciardi|
|17 Dec 2012||Author responded||Author comments - Tjalke Westra|
|Resubmission - Version 6|
|17 Dec 2012||Submitted||Manuscript version 6|
|25 Jan 2013||Editorially accepted|
|7 Feb 2013||Article published||10.1186/1471-2334-13-75|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.